Presenter of 3 Presentations
First Evidence with the MiniMedTM 780G System and FiAsp in Adolescents: the FACT study
Continuous and Intermittent Glucose Monitoring
Glucose control during exercise using automated insulin delivery in type 1 diabetes
Abstract
Abstract Body
While the benefits of regular physical activity are well established for individuals with type 1 diabetes, glucose control remains a challenge with conventional therapeutic tools, especially during and after physical activity. Factors affecting glycemic control include activity type (aerobic, anaerobic or mixed), intensity and duration of the activity, level of hydration, the secretion of counter-regulatory hormones as well as the amount of insulin and nutrients in the body, when the physical activity is performed.
Glucose-responsive automated insulin (and glucagon) delivery is now a routine clinical reality for many individuals living with type 1 diabetes. There are several automated insulin delivery systems are already available, at the same time there are several other devices extensively evaluated at home, mainly unsupervised, and for longer periods. The performance of automated insulin delivery devices has been challanged with different types of physical activity, using different exercise settings and duration, adding additional signals to detect physical activity, such as activity and heart rate monitoring, and including individuals with type 1 diabetes of different ages.
In this presentation, we will present current data on automated insulin delivery in type 1 diabetes challenged by physical activity.